Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open Extension Study Evaluating the Safety and Tolerability of Oral Ziprasidone in the Treatment of Subjects Who Have Successfully Completed a Previous Ziprasidone Study.

Trial Profile

Open Extension Study Evaluating the Safety and Tolerability of Oral Ziprasidone in the Treatment of Subjects Who Have Successfully Completed a Previous Ziprasidone Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Aug 2010

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 13 Jul 2010 Actual end date added to 1 Jun 2009 as reported by ClinicalTrials.gov.
    • 13 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Jun 2009 Actual patient number changed from 329 to 344 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top